# LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)

> **NCT05327361** · PHASE2 · TERMINATED · sponsor: **University of Miami** · enrollment: 13 (actual)

## Conditions studied

- Acne
- Post Inflammatory Hyperpigmentation

## Interventions

- **DRUG:** Liftactiv B3
- **OTHER:** Sunscreen

## Key facts

- **NCT ID:** NCT05327361
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-03-22
- **Primary completion:** 2023-01-17
- **Final completion:** 2023-03-06
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Enrollment timeline ended
- **Last updated:** 2024-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05327361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05327361, "LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05327361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*